Adventrx Pharmaceuticals (ANX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	20.52M
Interest and other receivables
Prepaid expenses
Total current assets	28.28M
Property and equipment, net	148K
In-process research and development
Goodwill	3.01M
Other assets	131K
Total assets	40.12M
Accounts payable	1.5M
Accrued liabilities	6.9M
Accrued compensation and payroll taxes	901K
Total current liabilities	20.89M
Contingent consideration
Common stock, $0.001 par value; 500,000,000 shares authorized; 26,465,709 and 15,480,302 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	233K
Additional paid-in capital	317.99M
Accumulated other comprehensive income	4K
Deficit accumulated during the development stage
Total stockholders' equity	13.19M
Total liabilities and stockholders' equity	40.12M

Entities mentioned with ANX

View All Entities